Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib-Reference-Cited by-同舟云学术

Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib

Published:2013-10-01 Issue:5 Volume:58 Page:1655-1666
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Vouche Michael¹,Kulik Laura²,Atassi Rohi¹,Memon Khairuddin¹,Hickey Ryan¹,Ganger Daniel²,Miller Frank H.¹,Yaghmai Vahid¹,Abecassis Michael³,Baker Talia³,Mulcahy Mary⁴,Nayar Ritu⁵,Lewandowski Robert J.¹,Salem Riad¹³⁴

Affiliation:

1. Department of Radiology; Section of Interventional Radiology and Division of Interventional Oncology; Northwestern University; Chicago IL

2. Department of Medicine; Division of Hepatology; Northwestern University; Chicago IL

3. Department of Surgery; Division of Transplantation; Northwestern University; Chicago IL

4. Department of Medicine; Division of Medical Oncology; Northwestern University; Chicago IL

5. Department of Surgical Pathology; Northwestern University; Chicago IL

Funder

National Instututes of Health

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26487/fullpdf

Reference27 articles.

1. Design and endpoints of clinical trials in hepatocellular carcinoma;Llovet;J Natl Cancer Inst,2008

2. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

3. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma;Lencioni;Semin Liver Dis,2010

4. Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation;Riaz;J Hepatol,2011

5. Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres;Riaz;Hepatology,2009

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of the Radiological Response on Histological Necrosis and on the Survival of Patients Treated With Transarterial Chemoembolization for Hepatocellular Carcinoma Secondary to Cirrhosis on the Liver Transplantation Waiting List;Transplantation Proceedings;2024-09

2. Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases;Radiology and Oncology;2024-02-21

3. Diffusion-weighted MRI (DWI) for assessment of response to high-dose-rate CT-guided brachytherapy (HDR-BT) of hepatocellular carcinoma;Acta Radiologica;2023-02-26

4. Procedural technique development;Translational Interventional Radiology;2023

5. TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis;Cancer Medicine;2022-08-09